Sheldon Sloan

Chief Medical Officer, Spyre Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$7.4M

Companies

Latest trade

Jul 1, 2026

Companies

Spyre Therapeutics, Inc.Chief Medical Officer −$7.4M

Trades

SYRE Sold 8,334 shares at $87.70 · planned $0.7M Jul 1

SYRE Sold 8,333 shares at $75.00 · planned $0.6M Jun 3

SYRE Sold 78,333 shares at $71.50 · planned $5.6M May 1

SYRE Sold 7,958 shares at $50.00 · planned $0.4M Apr 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.